Prism Medico Pharmacy Ltd vs Standard Shoe Sole Mould India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 35.05 as of 30 Oct 15:30 . The P/E Ratio of Prism Medico & Pharmacy Ltd changed from 47.6 on March 2026 to 47.6 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Standard Shoe Sole & Mould India Ltd changed from 2.9 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 7.06 crore on March 2021 to ₹ 15.29 crore on March 2026 . This represents a CAGR of 13.75% over 6 yearsThe Market Cap of Standard Shoe Sole & Mould India Ltd changed from ₹ 4.67 crore on March 2022 to ₹ 10.01 crore on March 2026 . This represents a CAGR of 16.47% over 5 years The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.28 crore. This represent the decline of -67.86% The revenue of Standard Shoe Sole & Mould India Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the decline of -50% The ebitda of Standard Shoe Sole & Mould India Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.04 crore. This represent the growth of 50% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ -0.09 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -16.49% The net profit of Standard Shoe Sole & Mould India Ltd changed from ₹ -0.07 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -6.62% The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Standard Shoe Sole & Mould India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

About Standard Shoe Sole & Mould India Ltd

Standard Shoe Sole and Mould (India) Limited was originally incorporated on 19 July, 1973 as Chemcrown India (Private) Limited with the Registrar of Companies, West Bengal.
Subsequently, the name of the Company was changed to its present name 'Standard Shoe Sole and Mould (India) Limited' and a fresh Certificate of Incorporation reflecting the new name was issued by Registrar of Companies, West Bengal on 14 December, 2001. The Company made its public issue in year 1991 and subsequently got its shares listed at BSE Limited in the same year.
The Company started off as a distributor for the leather chemicals manufactured by Sandoz (India) Ltd. Besides, the Company entered into the manufacture of leather chemicals. The Company had filed a reference on August 02, 1996 with the Board for Industrial and Financial Reconstruction (BIFR) in terms of Section 15 of Sick Industrial Company.

FAQs for the comparison of Prism Medico & Pharmacy Ltd and Standard Shoe Sole & Mould India Ltd

Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or Standard Shoe Sole & Mould India Ltd?

Market cap of Prism Medico & Pharmacy Ltd is 47 Cr while Market cap of Standard Shoe Sole & Mould India Ltd is 6 Cr

What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and Standard Shoe Sole & Mould India Ltd?

The stock performance of Prism Medico & Pharmacy Ltd and Standard Shoe Sole & Mould India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prism Medico & Pharmacy Ltd and Standard Shoe Sole & Mould India Ltd?

As of October 31, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹35.05. On the other hand, Standard Shoe Sole & Mould India Ltd stock price is INR ₹12.24.

How do dividend payouts of Prism Medico & Pharmacy Ltd and Standard Shoe Sole & Mould India Ltd compare?

To compare the dividend payouts of Prism Medico & Pharmacy Ltd and Standard Shoe Sole & Mould India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.